Forte Biosciences, Inc. (FBRX) Operating cash flow 2016–2025
Forte Biosciences, Inc. (FBRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$50.9MFY2025 · since FY2016: -$29.5M → -$50.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.9M | -65.5% |
| FY2024 | -$30.7M | -7.1% |
| FY2023 | -$28.7M | -250.7% |
| FY2022 | -$8.2M | +50.9% |
| FY2021 | -$16.7M | +9.5% |
| FY2020 | -$18.4M | -564.9% |
| FY2019 | -$2.8M | +92.0% |
| FY2018 | -$34.5M | -10.7% |
| FY2017 | -$31.1M | -5.4% |
| FY2016 | -$29.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice